HighTower Advisors LLC reduced its stake in Cigna Corporation (NYSE:CI) by 8.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 14,770 shares of the health services provider’s stock after selling 1,429 shares during the period. HighTower Advisors LLC’s holdings in Cigna Corporation were worth $2,164,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Thrivent Financial for Lutherans boosted its position in shares of Cigna Corporation by 6.0% in the fourth quarter. Thrivent Financial for Lutherans now owns 8,890 shares of the health services provider’s stock worth $1,186,000 after buying an additional 500 shares during the last quarter. Dodge & Cox acquired a new position in shares of Cigna Corporation during the fourth quarter worth approximately $1,929,534,000. UBS Asset Management Americas Inc. boosted its position in shares of Cigna Corporation by 78.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 1,305,749 shares of the health services provider’s stock worth $174,173,000 after buying an additional 573,696 shares during the last quarter. Teachers Advisors LLC boosted its position in shares of Cigna Corporation by 41.8% in the fourth quarter. Teachers Advisors LLC now owns 983,915 shares of the health services provider’s stock worth $131,244,000 after buying an additional 289,870 shares during the last quarter. Finally, Kentucky Retirement Systems acquired a new position in shares of Cigna Corporation during the fourth quarter worth approximately $2,485,000. Institutional investors own 86.95% of the company’s stock.

Shares of Cigna Corporation (NYSE CI) traded up 0.75% during trading on Thursday, hitting $176.05. The stock had a trading volume of 1,573,422 shares. The company has a market cap of $45.07 billion, a P/E ratio of 23.50 and a beta of 0.46. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $177.24. The stock has a 50-day moving average price of $170.76 and a 200 day moving average price of $157.68.

Cigna Corporation (NYSE:CI) last issued its quarterly earnings data on Friday, May 5th. The health services provider reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.33. The firm had revenue of $10.39 billion during the quarter, compared to analysts’ expectations of $10.11 billion. Cigna Corporation had a return on equity of 16.07% and a net margin of 6.53%. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.46 EPS. Equities analysts expect that Cigna Corporation will post $9.79 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Cigna Corporation (NYSE:CI) Shares Sold by HighTower Advisors LLC” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/03/cigna-corporation-nyseci-shares-sold-by-hightower-advisors-llc-updated-updated-updated.html.

CI has been the topic of a number of recent research reports. Deutsche Bank AG initiated coverage on shares of Cigna Corporation in a research report on Wednesday, April 5th. They set a “buy” rating and a $172.00 price target on the stock. Zacks Investment Research cut shares of Cigna Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, April 5th. Credit Suisse Group started coverage on shares of Cigna Corporation in a report on Monday, June 12th. They issued an “outperform” rating and a $185.00 target price on the stock. Jefferies Group LLC restated a “buy” rating and issued a $183.00 target price (up previously from $178.00) on shares of Cigna Corporation in a report on Friday, May 5th. Finally, Stifel Nicolaus raised their target price on shares of Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, May 5th. Two investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $176.61.

In other Cigna Corporation news, CEO David Cordani sold 153,168 shares of the stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $170.20, for a total value of $26,069,193.60. Following the completion of the sale, the chief executive officer now directly owns 421,162 shares in the company, valued at $71,681,772.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Mary T. Hoeltzel sold 500 shares of the stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $166.70, for a total value of $83,350.00. Following the completion of the sale, the vice president now owns 2,449 shares of the company’s stock, valued at $408,248.30. The disclosure for this sale can be found here. Insiders have sold a total of 219,558 shares of company stock valued at $37,135,665 over the last 90 days. 1.30% of the stock is currently owned by company insiders.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.